Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeted therapy clinical trials in ovarian cancer: improved outcomes by gene mutation screening.

Anti-cancer drugs - 1 Feb 2020

Guo Quan, Yang Qing, Li Jun, Liu Guipeng, Nikoulin Igor, Jia Steve

Abstract excerpt

Epithelial ovarian cancer is the most common and leading cause of death for gynaecologic cancer in the western world. Current standard treatments with limited selection of chemotherapies cannot meet patients' urgent needs. Novel targeted therapies may improve patients' survival rate with less side effects that have been demonstrated by using approved medicines such as poly ADP-ribose polymerase and angiogenesis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Biomarkers, Tumor
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Profiling

Share to Molecular Targeted Therapy

Share to Mutation

Share to Ovarian Neoplasms

Share to Treatment Outcome

Source

Identifiers

PMID: 31743133
DOI: 10.1097/CAD.0000000000000858

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeted therapy clinical trials in ovarian cancer: improved outcomes by gene mutation screening.PMID 31743133Read ↗

Targeted therapies and clinical trials in ovarian cancer.Semantic proximity Read ↗

Cellular Mechanism of Gene Mutations and Potential Therapeutic Targets in Ovarian CancerSemantic proximity Read ↗

Ovarian cancer: emerging molecular-targeted therapiesSemantic proximity Read ↗

Molecular/genetic therapies in ovarian cancer: future opportunities and challenges.Semantic proximity Read ↗

Ovarian cancer in 2011: Mutations and non-inferiority analyses show a way forward.Semantic proximity Read ↗

Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapiesSemantic proximity Read ↗

New ovarian cancer gene variations discovered. Findings may help target at-risk women for ovarian cancer screening and earlier treatment.Semantic proximity Read ↗

Better therapeutic trials in ovarian cancer.Semantic proximity Read ↗

The rise of genomic profiling in ovarian cancer.Semantic proximity Read ↗

Rational selection of biomarker driven therapies for gynecologic cancers: The more we know, the more we know we don't know.Semantic proximity Read ↗

Analysis of molecular aberrations in ovarian cancer allows novel target identification.Semantic proximity Read ↗

Genetic alterations and their therapeutic implications in epithelial ovarian cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.